Persons with chronic hepatitis B (HBV) infection and active viremia are infectious and may transmit virus to others through blood/body fluid exposure. Immune tolerant treatment naive persons with hepatitis B infection express anxiety regarding disclosure of their infection status and significant fear of transmission to their partners leading to social isolation and impact on their personal lives. This study will provide data correlating serum and body fluid viral levels in persons with chronic hepatitis B infection not on therapy and those with viral suppression on long-term anti-retroviral therapy (ART) that may support the concept of "Undetectable=Untransmissible" (U=U) in patients with chronic hepatitis B.
Study Type
OBSERVATIONAL
Enrollment
55
NYU Langone Health
New York, New York, United States
Percentage of Individuals with Detectable HBV DNA
Assessed among those who have achieved viral supression.
Time frame: Up to Month 6
HBV DNA Levels
Assessed among those with detectable HBV DNA.
Time frame: Up to Month 6
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.